What is Pfizer's xtandi — revenues:?

Pfizer (PFE) reported xtandi — revenues: of $444.00M in Q1 2026.

How has Pfizer's xtandi — revenues: changed year-over-year?

Pfizer's xtandi — revenues: decreased by 3.1% year-over-year, from $458.00M to $444.00M.

What is the long-term trend for Pfizer's xtandi — revenues:?

Over 3 years (2022 to 2025), Pfizer's xtandi — revenues: has grown at a 10.0% compound annual growth rate (CAGR), from $1.65B to $2.19B.

Products & Services · Revenues:

Xtandi — Revenues:

Pfizer Xtandi — Revenues: decreased by 25.0% to $444.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.1%, from $458.00M to $444.00M. Over 3 years (FY 2022 to FY 2025), Xtandi — Revenues: shows an upward trend with a 10.0% CAGR.

Analysis

StatementSegment

First reportedQ1 2022

Last reportedQ1 2026May 5, 2026

Rolls up toTotal Revenue

Metric ID: pfe_segment_xtandi_revenues

Historical Data

17 periods

	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$412.50M	$412.50M	$412.50M	$412.50M	$339.00M	$423.00M	$440.00M	$457.00M	$418.00M	$495.00M	$561.00M	$565.00M	$458.00M	$566.00M	$578.00M	$592.00M	$444.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	-17.8%	+24.8%	+4.0%	+3.9%	-8.5%	+18.4%	+13.3%	+0.7%	-18.9%	+23.6%	+2.1%	+2.4%	-25.0%
YoY Change	—	—	—	—	-17.8%	+2.5%	+6.7%	+10.8%	+23.3%	+17.0%	+27.5%	+23.6%	+9.6%	+14.3%	+3.0%	+4.8%	-3.1%

Range$339.00M – $592.00M

CAGR+1.9%

Avg YoY Growth+9.4%

Median YoY Growth+9.6%

Frequently Asked Questions

What is Pfizer's xtandi — revenues:?: Pfizer (PFE) reported xtandi — revenues: of $444.00M in Q1 2026.
How has Pfizer's xtandi — revenues: changed year-over-year?: Pfizer's xtandi — revenues: decreased by 3.1% year-over-year, from $458.00M to $444.00M.
What is the long-term trend for Pfizer's xtandi — revenues:?: Over 3 years (2022 to 2025), Pfizer's xtandi — revenues: has grown at a 10.0% compound annual growth rate (CAGR), from $1.65B to $2.19B.